MARIA TERESA
BERNAL DEL CASTILLO

Profesora Titular de Universidad

Foto de MARIA TERESA

Foto de Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia

Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia

Valencia, España

Publications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (6)

2025

Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study
Cancers, Vol. 17, Núm. 5

2024

Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Annals of Hematology, Vol. 103, Núm. 8, pp. 2845-2851
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry
Haematologica

2023

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
Blood Cancer Journal, Vol. 13, Núm. 1

2022

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
Cancers, Vol. 14, Núm. 23

2017

Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents
Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597